Similar articles

• Biofluid Detection of Pathological α-Synuclein in the Prodromal Phase of Synucleinopathies.

  Kluge A, Iranzo A. Kluge A, et al. J Parkinsons Dis. 2024;14(s2):S323-S331. doi: 10.3233/JPD-230429. J Parkinsons Dis. 2024. PMID: 38995801 Free PMC article.
• Ultrasensitive RT-QuIC Seed Amplification Assays for Disease-Associated Tau, α-Synuclein, and Prion Aggregates.

  Saijo E, Groveman BR, Kraus A, Metrick M, Orrù CD, Hughson AG, Caughey B. Saijo E, et al. Methods Mol Biol. 2019;1873:19-37. doi: 10.1007/978-1-4939-8820-4_2. Methods Mol Biol. 2019. PMID: 30341601
• α-Synuclein RT-QuIC assay in cerebrospinal fluid of patients with dementia with Lewy bodies.

  Bongianni M, Ladogana A, Capaldi S, Klotz S, Baiardi S, Cagnin A, Perra D, Fiorini M, Poleggi A, Legname G, Cattaruzza T, Janes F, Tabaton M, Ghetti B, Monaco S, Kovacs GG, Parchi P, Pocchiari M, Zanusso G. Bongianni M, et al. Ann Clin Transl Neurol. 2019 Oct;6(10):2120-2126. doi: 10.1002/acn3.50897. Epub 2019 Oct 10. Ann Clin Transl Neurol. 2019. PMID: 31599499 Free PMC article.
• CSF Biomarkers for Early Diagnosis of Synucleinopathies: Focus on Idiopathic RBD.

  Liguori C, Paoletti FP, Placidi F, Ruffini R, Sancesario GM, Eusebi P, Mercuri NB, Parnetti L. Liguori C, et al. Curr Neurol Neurosci Rep. 2019 Jan 14;19(2):3. doi: 10.1007/s11910-019-0918-y. Curr Neurol Neurosci Rep. 2019. PMID: 30637520 Review.
• Synucleinopathies: Where we are and where we need to go.

  Brás IC, Dominguez-Meijide A, Gerhardt E, Koss D, Lázaro DF, Santos PI, Vasili E, Xylaki M, Outeiro TF. Brás IC, et al. J Neurochem. 2020 May;153(4):433-454. doi: 10.1111/jnc.14965. Epub 2020 Feb 19. J Neurochem. 2020. PMID: 31957016 Review.